chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to animal, Anaemia, Chest pain, Epistaxis, Giant cell arteritis
Clinical narrative: In August 2022 I had an allergic reaction to a dog that I had never had before.  Later that month, I developed a respiratory infection with fever and anemia.  That infection turned into a tight jaw and then to my neck and my knees.  In January I had a frozen shoulder.  I had 7 major nose bleeds between February and March 2023.  The ENT did a procedure to help with this.  In March 2023 I saw a rheumatologist for some testing.  I was diagnosed with giant cell arteritis.  Later in March I also had chest pain and I was diagnosed in the emergency department with mild myopericarditis.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Muscle tightness, Myopericarditis, Periarthritis, Pyrexia
Clinical narrative: In August 2022 I had an allergic reaction to a dog that I had never had before.  Later that month, I developed a respiratory infection with fever and anemia.  That infection turned into a tight jaw and then to my neck and my knees.  In January I had a frozen shoulder.  I had 7 major nose bleeds between February and March 2023.  The ENT did a procedure to help with this.  In March 2023 I saw a rheumatologist for some testing.  I was diagnosed with giant cell arteritis.  Later in March I also had chest pain and I was diagnosed in the emergency department with mild myopericarditis.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract infection, Surgery
Clinical narrative: In August 2022 I had an allergic reaction to a dog that I had never had before.  Later that month, I developed a respiratory infection with fever and anemia.  That infection turned into a tight jaw and then to my neck and my knees.  In January I had a frozen shoulder.  I had 7 major nose bleeds between February and March 2023.  The ENT did a procedure to help with this.  In March 2023 I saw a rheumatologist for some testing.  I was diagnosed with giant cell arteritis.  Later in March I also had chest pain and I was diagnosed in the emergency department with mild myopericarditis.
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Hypotension, Plasma cell myeloma
Clinical narrative: HYPOTENSION 8/19/2022 ANEMIA HYPOTENSION 8/19/2022 MULTIPLE MYELOMA
Age: 1.75
Sex: M
Vaccine: DTAP, HIBV, PNC13
Symptoms: Urticaria
Clinical narrative: Whole body hives 7-8 days after immunization
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dehydration, Depressed level of consciousness, Disturbance in attention, SARS-CoV-2 test positive
Clinical narrative: I tested positive for COVID-19 in April 2022. I was semi-conscious on the floor of my room and one of the healthcare workers at the retirement home found me and I was taken to the hospital. I can't recall many symptoms, but I was unable to focus. I can remember that. They said I was extremely dehydrated. They told me I also had a UTI as well. I was given medication, but I am unable to recall the names of them.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: I tested positive for COVID-19 in April 2022. I was semi-conscious on the floor of my room and one of the healthcare workers at the retirement home found me and I was taken to the hospital. I can't recall many symptoms, but I was unable to focus. I can remember that. They said I was extremely dehydrated. They told me I also had a UTI as well. I was given medication, but I am unable to recall the names of them.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Computerised tomogram, Hypoaesthesia, Laboratory test, Magnetic resonance imaging
Clinical narrative: Within two hours, swelling and sore arm, numbness in arm. The extreme soreness and numbness continues to this day. I never have had this happen before - to last over a year from a vaccination. In addition, I suffered a stroke on June 14, 2022 which required hospitalization. After leaving the hospital I was recovering at my son's home for months before returning to my home. I still have lingering symptoms from the stroke in addition to the extremely sore arm and numbness.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Within two hours, swelling and sore arm, numbness in arm. The extreme soreness and numbness continues to this day. I never have had this happen before - to last over a year from a vaccination. In addition, I suffered a stroke on June 14, 2022 which required hospitalization. After leaving the hospital I was recovering at my son's home for months before returning to my home. I still have lingering symptoms from the stroke in addition to the extremely sore arm and numbness.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety disorder, Neuropathy peripheral, Respiratory failure
Clinical narrative: NEUROPATHY 5/19/2021 UNSPECIFIED ANXIETY DISORDER  RESPIRATORY FAILURE, UNSPECIFIED ACUITY 10/5/2021 UNSPECIFIED ANXIETY DISORDER
Age: 33.0
Sex: F
Vaccine: JEV1, RAB
Symptoms: Feeling abnormal, Immediate post-injection reaction, Nausea, Pain in extremity, Pallor
Clinical narrative: Client complained of instant pain and soreness in L arm after receiving Rabies vaccine. After about 5 mins, client stated she felt nauseous and didn't feel good, face was pale. Helped client to recliner, reclined chair, elevated legs, gave her a water bottle and sucker. Client then stated both of her hands felt tingly. Stayed with client and after a few minutes client started feeling better. Client remained in recliner for another 15 minutes. Client left office feeling better; nausea, pain in arm and tingling in fingers had resolved.
Age: 33.0
Sex: F
Vaccine: JEV1, RAB
Symptoms: Paraesthesia
Clinical narrative: Client complained of instant pain and soreness in L arm after receiving Rabies vaccine. After about 5 mins, client stated she felt nauseous and didn't feel good, face was pale. Helped client to recliner, reclined chair, elevated legs, gave her a water bottle and sucker. Client then stated both of her hands felt tingly. Stayed with client and after a few minutes client started feeling better. Client remained in recliner for another 15 minutes. Client left office feeling better; nausea, pain in arm and tingling in fingers had resolved.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac failure acute, Cardiac failure congestive, Coronary artery disease, Hypotension, Left ventricular failure
Clinical narrative: I95.9 HYPOTENSION 9/2/2022 COMBINED SYSTOLIC AND DIASTOLIC HEART FAILURE, ACUTE ON CHRONIC I95.9 HYPOTENSION 9/2/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED I95.9 HYPOTENSION 9/2/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Balance disorder, Tremor
Clinical narrative: Patient stated he experienced hand tremors and unsteadiness for 4 days. Stated he was walking like he was "drunk."
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Laboratory test abnormal, Maculopathy, Photopsia, Visual field defect
Clinical narrative: I began to see flashes in both eyes early October 2022 which began going away a couple weeks into October 2022. In place of the flashes I began to develop grey spots that occlude central vision partially. I still have this issue as of typing this.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Coagulopathy, Pneumonia
Clinical narrative: D68.9 COAGULOPATHY, UNSPECIFIED TYPE 9/2/2022 PNEUMONIA I21.4 ACUTE NON ST ELEVATION MI 9/2/2022 PNEUMONIA
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Dizziness
Clinical narrative: Patient felt dizzy after vaccine had been administered. Patient laid down and waited 15 post injection and felt better before being let go from clinic.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Decreased appetite, Headache, Respiratory tract congestion
Clinical narrative: Contracted COVID  for a 2nd time with symptoms of scratchy throat, headache, loss of appetite, persistent cough, congestion,, mucus.  Went to urgent care facility, as directed by my internal med doctor and received treatment.  Nurse took the following:  Blood pressure, temperature,, height and weight.  Tested positive for administered COVID test.  PA-C  prescribed Paxlovid medication (150  mg)  taken over a period of 5 days. Quarantinee for a period.of 10 days.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Secretion discharge, Throat irritation
Clinical narrative: Contracted COVID  for a 2nd time with symptoms of scratchy throat, headache, loss of appetite, persistent cough, congestion,, mucus.  Went to urgent care facility, as directed by my internal med doctor and received treatment.  Nurse took the following:  Blood pressure, temperature,, height and weight.  Tested positive for administered COVID test.  PA-C  prescribed Paxlovid medication (150  mg)  taken over a period of 5 days. Quarantinee for a period.of 10 days.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Amyloidosis, Bradycardia, Central sleep apnoea syndrome, Hypotension
Clinical narrative: CENTRAL SLEEP APNEA IN CONDITIONS CLASSIFIED ELSEWHERE 10/25/2021 AMYLOIDOSIS, UNSPECIFIED CENTRAL SLEEP APNEA IN CONDITIONS CLASSIFIED ELSEWHERE 10/25/2021 HYPOTENSION CENTRAL SLEEP APNEA IN CONDITIONS CLASSIFIED ELSEWHERE 10/25/2021 BRADYCARDIA
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Respiratory failure
Clinical narrative: J96.90 RESPIRATORY FAILURE, UNSPECIFIED ACUITY 12/17/2021 CARDIAC ARREST CAUSE UNSPECIFIED
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Dermatitis, Haematemesis, Hypotension, Sepsis
Clinical narrative: Pfizer vaccine was administered outside of the clinic - reported by patient- ? NO LOT NUMBER WERE SUPPLIED -------------------------------------------------------------------------------------------------------------------------------- HYPOTENSION 12/10/2021 DERMATITIS ACUTE RESPIRATORY FAILURE 1/10/2022 DERMATITIS ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/10/2021 DERMATITIS SHOCK, UNSPECIFIED 12/10/2021 DERMATITIS HYPOTENSION 12/10/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION, W MSSA SEPTICEMIA ACUTE RESPIRATORY FAILURE 1/10/2022 SEPSIS WO ACUTE ORGAN DYSFUNCTION, W MSSA SEPTICEMIA ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/10/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION, W MSSA SEPTICEMIA SHOCK, UNSPECIFIED 12/10/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION, W MSSA SEPTICEMIA HYPOTENSION 12/10/2021 HEMATEMESIS ACUTE RESPIRATORY FAILURE 1/10/2022 HEMATEMESIS ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/10/2021 HEMATEMESIS SHOCK, UNSPECIFIED 12/10/2021 HEMATEMESIS HYPOTENSION 12/10/2021 URINARY RETENTION ACUTE RESPIRATORY FAILURE 1/10/2022 URINARY RETENTION ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/10/2021 URINARY RETENTION SHOCK, UNSPECIFIED 12/10/2021 URINARY RETENTION
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Shock, Staphylococcal sepsis, Urinary retention
Clinical narrative: Pfizer vaccine was administered outside of the clinic - reported by patient- ? NO LOT NUMBER WERE SUPPLIED -------------------------------------------------------------------------------------------------------------------------------- HYPOTENSION 12/10/2021 DERMATITIS ACUTE RESPIRATORY FAILURE 1/10/2022 DERMATITIS ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/10/2021 DERMATITIS SHOCK, UNSPECIFIED 12/10/2021 DERMATITIS HYPOTENSION 12/10/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION, W MSSA SEPTICEMIA ACUTE RESPIRATORY FAILURE 1/10/2022 SEPSIS WO ACUTE ORGAN DYSFUNCTION, W MSSA SEPTICEMIA ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/10/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION, W MSSA SEPTICEMIA SHOCK, UNSPECIFIED 12/10/2021 SEPSIS WO ACUTE ORGAN DYSFUNCTION, W MSSA SEPTICEMIA HYPOTENSION 12/10/2021 HEMATEMESIS ACUTE RESPIRATORY FAILURE 1/10/2022 HEMATEMESIS ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/10/2021 HEMATEMESIS SHOCK, UNSPECIFIED 12/10/2021 HEMATEMESIS HYPOTENSION 12/10/2021 URINARY RETENTION ACUTE RESPIRATORY FAILURE 1/10/2022 URINARY RETENTION ACUTE HYPOXEMIC RESPIRATORY FAILURE 12/10/2021 URINARY RETENTION SHOCK, UNSPECIFIED 12/10/2021 URINARY RETENTION
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Seizure, Subdural haematoma
Clinical narrative: HYPOXIA 1/18/2022 TRAUMATIC SUBDURAL HEMATOMA, INIT HYPOXIA 1/18/2022 SEIZURE, UNSPECIFIED HYPOXIA 1/18/2022 SEIZURE, UNSPECIFIED
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I had a cough, congestion, I took a home COVID-19 test that came back negative.  I made an appointment with my doctor, I had a telehealth visit, we discussed my symptoms and negative test.  I was given Ciprofloxacin, Benzonatate, Albuterol Inhaler. I started taking the medication immediately, I am starting to feel better.
Age: 72.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: COVID-19, Cough, Fatigue, Pyrexia, Rhinorrhoea
Clinical narrative: In the afternoon I started coughing. Cough got worse the next day and I got tested the next day. Rapid COVID-19 test positive. I saw the Cruise ship doctor and they treated symptomatically and provided a Z-PAK. Symptoms got a little more intense, 5/1 I got a fever, and then everything got slowly better. Just a sniffle, a cough, and fatigue linger at time of reporting.
Age: 72.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: SARS-CoV-2 test positive
Clinical narrative: In the afternoon I started coughing. Cough got worse the next day and I got tested the next day. Rapid COVID-19 test positive. I saw the Cruise ship doctor and they treated symptomatically and provided a Z-PAK. Symptoms got a little more intense, 5/1 I got a fever, and then everything got slowly better. Just a sniffle, a cough, and fatigue linger at time of reporting.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Hypoxia, Organ failure, Respiratory failure
Clinical narrative: Moderna vaccine was administered outside of clinic- reported by patient ? NO LOT NUMBER WERE SUPPLIED ----------------------------------------------------------------------------------------------------------------------------  CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 8/8/2021 HYPOXIA  ACUTE ON CHRONIC RESPIRATORY FAILURE 8/5/2021 HYPOXIA  ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/12/2021 HYPOXIA  CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 8/8/2021 UTI (URINARY TRACT INFECTION)  ACUTE ON CHRONIC RESPIRATORY FAILURE 8/5/2021 UTI (URINARY TRACT INFECTION)  ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/12/2021 UTI (URINARY TRACT INFECTION)  CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 8/8/2021 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION  ACUTE ON CHRONIC RESPIRATORY FAILURE 8/5/2021 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION  ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/12/2021 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis, Urinary tract infection
Clinical narrative: Moderna vaccine was administered outside of clinic- reported by patient ? NO LOT NUMBER WERE SUPPLIED ----------------------------------------------------------------------------------------------------------------------------  CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 8/8/2021 HYPOXIA  ACUTE ON CHRONIC RESPIRATORY FAILURE 8/5/2021 HYPOXIA  ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/12/2021 HYPOXIA  CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 8/8/2021 UTI (URINARY TRACT INFECTION)  ACUTE ON CHRONIC RESPIRATORY FAILURE 8/5/2021 UTI (URINARY TRACT INFECTION)  ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/12/2021 UTI (URINARY TRACT INFECTION)  CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 8/8/2021 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION  ACUTE ON CHRONIC RESPIRATORY FAILURE 8/5/2021 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION  ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/12/2021 SEVERE SEPSIS W ACUTE ORGAN DYSFUNCTION
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Anxiety disorder, Cerebrovascular accident, Chronic respiratory failure, Coronary artery disease
Clinical narrative: ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 10/4/2021 UNSPECIFIED ANXIETY DISORDER  ACUTE RESPIRATORY FAILURE 10/25/2021 UNSPECIFIED ANXIETY DISORDER  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/19/2022 UNSPECIFIED ANXIETY DISORDER  HYPOXIA 1/18/2022 UNSPECIFIED ANXIETY DISORDER  ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 10/4/2021 UNSPECIFIED ANXIETY DISORDER  ACUTE RESPIRATORY FAILURE 10/25/2021 UNSPECIFIED ANXIETY DISORDER  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/19/2022 UNSPECIFIED ANXIETY DISORDER  HYPOXIA 1/18/2022 UNSPECIFIED ANXIETY DISORDER  ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 10/4/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE RESPIRATORY FAILURE 10/25/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/19/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA  HYPOXIA 1/18/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 10/4/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE RESPIRATORY FAILURE 10/25/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/19/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA  HYPOXIA 1/18/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Respiratory failure
Clinical narrative: ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 10/4/2021 UNSPECIFIED ANXIETY DISORDER  ACUTE RESPIRATORY FAILURE 10/25/2021 UNSPECIFIED ANXIETY DISORDER  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/19/2022 UNSPECIFIED ANXIETY DISORDER  HYPOXIA 1/18/2022 UNSPECIFIED ANXIETY DISORDER  ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 10/4/2021 UNSPECIFIED ANXIETY DISORDER  ACUTE RESPIRATORY FAILURE 10/25/2021 UNSPECIFIED ANXIETY DISORDER  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/19/2022 UNSPECIFIED ANXIETY DISORDER  HYPOXIA 1/18/2022 UNSPECIFIED ANXIETY DISORDER  ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 10/4/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE RESPIRATORY FAILURE 10/25/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/19/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA  HYPOXIA 1/18/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 10/4/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE RESPIRATORY FAILURE 10/25/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/19/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA  HYPOXIA 1/18/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA
Age: 52.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Abdominal pain, Blood test abnormal, Sensory disturbance, White blood cell count increased
Clinical narrative: Early in the morning on 4/10/2023, I noticed that I had abdominal pain and sensations that weren't consistent with those that accompany bowel movements (or the need to make them). The pain was still present, but not unbearable, on 4/11/2023. On 4/12/2023, the pain was still present, and I thought that I should be seen by a doctor. On that afternoon, I saw a NP. Based on the area of where the pain was concentrated, the NP thought that I could either have an ovarian cyst or diverticulitis. She then ordered a clear diet and some bloodwork. Bloodwork results indicated that my white blood cell count was high, so I was prescribed amoxicillin-clavulanic acid on 4/14/2023. I was instructed to keep the antibiotic as a standby, as the clinic would be closed for a holiday the following Monday. Overnight, from 4/14/2023 to 4/15/2023, I had abdominal pains that I would compare to those of childbirth. On 4/15/2023, I began taking the amoxicillin-clavulanic acid. By 4/16/2023, I felt much better. I continued the course of antibiotics and ate a bland diet to give my gut a chance to heal. I finished the complete course of seven days, and everything is great now.
Age: 38.0
Sex: M
Vaccine: HEP, MMR
Symptoms: Angina pectoris, Blood glucose decreased, Dyspnoea, Erythema, Feeling hot
Clinical narrative: About 45 to 60 minutes after receiving the vaccinations, pt. stated he started to feel warm, his heart started racing, and he had difficulty breathing.  He was feeling some slight heart pain.  His face turned red and he experienced blurred vision.  He was taken by paramedics to the Emergency Department at a nearby hospital.  At the ER, he was informed that he had hypertension, low blood sugar and a UTI.  (note; he did not eat prior to receiving the vaccinations)
Age: 38.0
Sex: M
Vaccine: HEP, MMR
Symptoms: Hypertension, Palpitations, Urinary tract infection, Vision blurred
Clinical narrative: About 45 to 60 minutes after receiving the vaccinations, pt. stated he started to feel warm, his heart started racing, and he had difficulty breathing.  He was feeling some slight heart pain.  His face turned red and he experienced blurred vision.  He was taken by paramedics to the Emergency Department at a nearby hospital.  At the ER, he was informed that he had hypertension, low blood sugar and a UTI.  (note; he did not eat prior to receiving the vaccinations)
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Actinic keratosis, Acute respiratory failure, Pulmonary embolism
Clinical narrative: PULMONARY EMBOLISM, UNSPECIFIED. 8/16/2021 ACTINIC KERATOSIS  ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/16/2021 ACTINIC KERATOSIS
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardiac failure, Hypoxia
Clinical narrative: R09.02 HYPOXIA 7/2/2021 ATRIAL FIBRILLATION, UNSPECIFIED R09.02 HYPOXIA 7/2/2021 HEART FAILURE W REDUCED LVEF 41-49%, UNSPECIFIED ACUITY
Age: 7.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Circumstance or information capable of leading to medication error, Extra dose administered, No adverse event
Clinical narrative: HCP called to report that she accidentally gave the patient an extra dose of VARIVAX. No additional AE/PQC; HCP called to report that she accidentally gave the patient an extra dose of VARIVAX. No additional AE/PQC; third dose of VAQTA on 6/21/2022; fourth dose of MMR II on 4/19/2022; third dose of MMR II on 1/12/2022; This spontaneous report was received from a registered nurse and refers to a 7-year-old male patient with milk protein and soy allergies, neonatal abstinence syndrome, neonatal stroke, attention deficit hyperactivity disorder (ADHD), and autism. His medical history was not reported. Concomitant medications included sterile diluent (STERILE DILUENT), diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) tetanus vaccine toxoid (DTAP) and hepatitis b vaccine (HEP-B-VAX). He had no adverse event following prior vaccination.  On an unknown date, the patient was vaccinated with the third dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U030162, expiration date: 28-SEP-2023, administered subcutaneously in right arm (dose was not provided). On 12-JAN-2022, he was administered with the third dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5 milliliter, lot #T033815, expiration date: 05-OCT-2022, administered subcutaneously in right arm (extra dose administered). Then, on 19-APR-2022, he received the fourth dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, 0.5 milliliter, lot #T034392, expiration date: 08-OCT-2022, administered subcutaneously in right arm (extra dose administered). On that date, the patient was also administered with polio vaccine. On 21-JUN-2022, the patient received the third dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 0.5 milliliter, lot #U024505, expiration date: 15-OCT-2022, administered intramuscularly in left deltoid (extra dose administered). The HCP said the patient went to a different pediatrician in 2022, and the pediatrician was unsure of the patient's vaccination history. So, due to the unknown vaccination history (incomplete and inaccurate vaccine documentation), the patient received these extra doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and hepatitis a vaccine, inactivated (VAQTA) in 2022. On 06-APR-2023, the patient was accidentally vaccinated with the fourth dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #W024335, expiration date: 01-AUG-2024, administered subcutaneously in left arm (extra dose administered). All vaccines were administered for prophylaxis. No adverse events were reported.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AEs; Vaccine was administered after temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. No information on patient' pertinent medical history, concomitant medications, drug reaction or allergies was provided.  On 24-JAN-2023, the patient was vaccinated with 1 dose of improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # W02294 is an invalid lot number for varicella virus vaccine live (Oka/Merck) (VARIVAX), expiration date reported as 13-JUL-2024, strength and route were unknown) for prophylaxis (product storage error). The vaccine was exposed to 6.9 degrees Fahrenheit (F) for 15 minutes. Previous temperature excursion included 7.1F for 0 hours 30 minutes 0 seconds and 11.6F for 1 hour 0 minutes 0 seconds. No additional adverse event was reported.
Age: 1.08
Sex: M
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No Adverse event; Temperature excursion; This spontaneous report was received from a medical assistant and refers to a 13-month-old male patient. There was no information about the patient's concurrent conditions, concomitant therapies, or medical history provided.  On 23-FEB-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection, lot #W006412, expiration date: 23-FEB-2024, administered intramuscularly (IM) in right thigh for prophylaxis (strength, dose, and frequency were not provided). It was reported that the vaccine had undergone temperature excursion and it was stored in the temperature range -14 to -10 degree Celsius by 1 hour on 20-JAN-2023 (product storage error). No additional adverse event (AE) reported.; Sender's Comments:  US-009507513-2303USA002114:MSD
Age: 1.25
Sex: M
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE reported; Improperly stored vaccine was administered to patient; This spontaneous report was received from a medical assistant and refers to a 15-month-old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported  On 08-DEC-2022, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) injection, administered intramuscularly in right thigh for prophylaxis, lot #W018828, expiration date: 14-JUN-2024 (lot #W018828 has been verified to be a valid lot number for varicella virus vaccine live (oka/merck) [VARIVAX]). Administered vaccine varicella virus vaccine live (oka/merck) (VARIVAX) had undergone temperature excursion on 05-DEC-2022 (Product storage error). There were no adverse events reported (no adverse event).  This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-2304USA007822:Original Case : 2303USA002114 US-009507513-2304USA007836:Original Case : 2303USA002114 US-009507513-2304USA007843:Original Case : 2303USA002114 US-009507513-2304USA007931:
Sex: F
Vaccine: MMR
Symptoms: Fatigue, Headache, Laziness, Malaise, Pyrexia
Clinical narrative: gainning more weight/eats twice a day; feeling tired; lazy; Stated she is currently sick; getting fever; getting fever & headaches; This spontaneous report has been received from a consumer, referring a female patient of unknown age. Concomitant medications included tofacitinib citrate (XELJANZ XR). The patient's medical history, and concurrent conditions were not provided.  On an unknown date of 2022 (also reported as last year) the patient was vaccinated with one dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) subcutaneous injection (strength, dose, frequency, administration route, lot number, and expiry date were not provided) indicated as prophylaxis.  On an unknown date, the patient started gaining more weight but eats twice a day (weight increased), was feeling tired (fatigue), lazy (laziness) and was getting sick every other week (illness). She was currently sick and had lasted approximately 10 days with fever (pyrexia) and headaches.  The outcome of the events and the causality assessment was not provided.
Sex: F
Vaccine: MMR
Symptoms: Weight increased
Clinical narrative: gainning more weight/eats twice a day; feeling tired; lazy; Stated she is currently sick; getting fever; getting fever & headaches; This spontaneous report has been received from a consumer, referring a female patient of unknown age. Concomitant medications included tofacitinib citrate (XELJANZ XR). The patient's medical history, and concurrent conditions were not provided.  On an unknown date of 2022 (also reported as last year) the patient was vaccinated with one dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) subcutaneous injection (strength, dose, frequency, administration route, lot number, and expiry date were not provided) indicated as prophylaxis.  On an unknown date, the patient started gaining more weight but eats twice a day (weight increased), was feeling tired (fatigue), lazy (laziness) and was getting sick every other week (illness). She was currently sick and had lasted approximately 10 days with fever (pyrexia) and headaches.  The outcome of the events and the causality assessment was not provided.
Sex: U
Vaccine: RV5
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AEs; expired dose of ROTATEQ was administered.; This spontaneous report was received from a nurse and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were not reported.  On 25-APR-2023, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 2 milliliter, lot #U038854, expiration date: 20-APR-2023, administered orally for prophylaxis (strength was not provided) (expired product administered). No additional adverse events (AEs).
Sex: U
Vaccine: HPV9
Symptoms: Vaccination site cellulitis
Clinical narrative: HCP reported that a 15 year old received their second dose of the vaccine on 04/04/2024 and seen 3 weeks later for cellulitis. The cellulitis developed on the same arm were the; This spontaneous report was received by customer and refers to a 15-year-old patient of unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 04-APR-2023, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (lot #, expiration date, exact dose, route of administration and anatomical location were not reported) for prophylaxis.  On unspecified day in April 2023 (reported as 3 weeks later), the patient experienced vaccination site cellulitis. The cellulitis developed on the same arm were the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (also reported as: GARDISAL 9) was injected. The outcome of vaccination site cellulitis was unknown.  The causality assessment was not provided.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AEs; HBP with responsibility for vaccine storage calling to report a temperature excursion. Product administered. No additional AEs. No PQCs.     ?    Names of vaccines involved (including lot/exp) VARIVAX W025273 08/10/2024        ?    Temperature: -; This spontaneous report was received from an administrator referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.      On 11-APR-2023, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) (dose and route of administration not reported) lot number W025273, expiration date 10-AUG-2024 for prophylaxis (product storage error). No adverse event was reported.  The temperature excursion of the vaccine was of -10 degrees Celsius for 59 minutes. No other excursions were detected.
Sex: U
Vaccine: RV5
Symptoms: No adverse event, Product storage error
Clinical narrative: Caller states 1 dose of ROTATEQ was administered to unknown patients. No additional AE reported. No PQC reproted.   Names of vaccines involved  ROTATEQ (unspecified lot/exp)  Temperature/Time frame 0.8C for  8 Hours 2 Minutes 1.5C for 4 Hours 56 Minu; No additional AE reported; This spontaneous report as received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.      On an unknown date, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent(ROTATEQ) oral (dose, lot number and expiration date not reported) for prophylaxis (product storage error). No adverse event was reported.  The temperature excursion of the vaccine was of 0.8 degrees Celsius (°C) for 8 hours and 2 minutes; 1.5°C for 4 hours and 56 minutes; 1°C for 7 hours and 14 minutes and 10.1°C for 34 minutes. No other excursions were detected.
Sex: M
Vaccine: RV5
Symptoms: Haematochezia, Rotavirus test positive
Clinical narrative: blood in stool; tested positive for ROTAVIRUS; This spontaneous report was received from a physician and referred to a 4-year-old male patient. The patient's medical history, concurrent conditions, concomitant therapies, drug reactions and allergies were unknown by reporter.  On an unknown date, the patient received complete series of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, administered orally for prophylaxis (strength, dose, lot #, and expiry date were not provided).  On approximately 17-APR-2023 (reported as 2 weeks), the patient experienced blood in stool (haematochezia) and tested positive for rotavirus. On an unknown date in 2023, patient was treated with Vancomycin and symptoms resolved within 24 hours of treatment.  The causal relationship between both the events and rotavirus vaccine, live, oral, pentavalent (ROTATEQ) was not reported.   Upon internal review, the event haematochezia was determined to be medically significant.  This is one of two reports from the same reporter.; Sender's Comments:  US-009507513-2305USA000766:
Age: 14.0
Sex: M
Vaccine: HPV4
Symptoms: Asthma, Nasopharyngitis, Wheezing
Clinical narrative: asthma attack; This spontaneous report was received from a consumer via company representative and referring to a 14-year-old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 18-APR-2023 (also reported as on Tuesday), the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) intramuscular injection, administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided).  On 23-APR-2023 (also reported as Sunday), cold allergy-like symptoms began. On 25-APR-2023, the patient was admitted to the hospital for severe asthma attack. On 28-APR-2023, the patient was discharged from the hospital. To date, he was still wheezing, but slowly recovering with medication. Therefore, the outcome of asthma attack was recovering.   The causal relationship between asthma attack and quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) was not reported.
Sex: U
Vaccine: HEP
Symptoms: Incorrect dose administered, No adverse event, Underdose
Clinical narrative: No adverse effects reported; HCP called to report an AE.  An adult patient was inadvertently administered a pediatric dose of RECOMBIVAX. No adverse effects reported.  Cross reference with cases 02381997 and 02381963. No additional AE/No PQC.; This spontaneous report was received from a nurse, regarding an adult patient of unspecified age and gender.     The patient's medical history, concurrent medication, concomitant medication, and allergies were not provided.   On 01-MAY-2023, the patient was inadvertently vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) dose of 0.5 mL (pediatric dose) (Incorrect dose administered) (frequency, route of administration, Lot #, and expiration date were not reported) as prophylaxis. No adverse events were reported.
Sex: U
Vaccine: HPV9
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No AE/PQC reported; Nurse calling to report patient was accidentally administered an extra dose of GARDASIL 9. Patient initially completed the 0,2,6 month regiment in 2016 and was administered a 4th dose today. Caller did not have any additional information. Permission; This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant medications, previous drug reactions, or allergies were not reported.  On 02-MAY-2023, the patient was accidentally vaccinated with an extra dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (strength, anatomical site of vaccination and route of administration were not reported; lot number W026977, expiration date reported and validated as 04-JAN-2025) as prophylaxis. The patient initially completed the 0, 2 and 6 month regimen in 2016 and was administered a fourth dose (extra dose administered). No adverse event reported.
Age: 27.0
Sex: U
Vaccine: HEP
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE; inadvertent administration of an expired dose of RECOMBIVAX HB; This spontaneous report was received from a pharmacist, referring to a 27-year-old patient with unknown gender. The patient's concomitant therapy, concurrent condition, medical history and drug reactions/allergies were not reported.  On 02-MAY-2023 (reported as today), the patient was inadvertently vaccinated with an expired dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (dose was 1 milliliter (ml), expiration date was reported as January 2023, lot number, route and anatomical location were not provided) for prophylaxis (expired product administered). The reporter inquired about inadvertent administration of an expired dose of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) and the potency of the dose. No adverse effects and no additional adverse event (AE) reported (no adverse event).
Age: 1.0
Sex: F
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE/PQC; HCP called to report patient was given a dose of PROQUAD that was stored outside of prescribing information temperatures. Product TE outcome was supported( case 02370482); This spontaneous report has been received from a health care professional, regarding a 1-year-old female patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 11-APR-2023, the patien was vaccinated with an improperly storage dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) injection, at a dose of 0.5 milliliters (ml) subcutaneously in the left arm on a private doctor's office/hospital with public funds as prophylaxis (lot number: W036931, which was determined to be valid, with an expiration date on 19-MAY-2024).  The administered dose underwent a temperature excursion of 9.8 degrees Fahrenheit (F) for 1 hour and 42 minutes as a result of a reading from a digital data logger, because the power blipped, and the temperature went up to 9.8 degrees Fahrenheit (F) for 1 hour and 43 minutes. There was not any previous temperature excursion reported. (Product storage error)  No additional adverse event was reported, and no further information provided.   This case is one of two reports from the same reporter.
Sex: U
Vaccine: MMRV
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE reported; Caller was Healthcare Business Professional who was in charge of vaccine storage/stability. Caller reported AE for Patient.  As confirmed by Caller at current call time, Patient who was previously seen by Separate Facility, This spontaneous report was received from Healthcare Business Professional and refers to a patient of unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 29-JAN-2023, the patient started therapy with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, unk, lot #K010209, expiration date: 17-JAN-2016, administered for prophylaxis (strength, and route of administration were not provided).  On 29-JAN-2023, as confirmed by caller at current call time, the patient who was previously seen by Separate  Facility, was administered expired measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) by Unknown Healthcare Professional from Corresponding, Separate Facility, (Expired vaccine used). Caller was unable to further clarify these statements at current call time. Caller was unable to confirm whether or not Affected Product had encountered any Temperature Excursions prior to or at event time. No AE Letter was sent since Caller did not wish for Caller to be contacted in future regarding event. No additional AE reported. No PQC reported. No further information provided.
Age: 12.0
Sex: M
Vaccine: HPV9
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE reported; Customer reported expired GARDASIL 9 got administered to a patient today 03MAY2023.; This spontaneous report was received from certified medicall assistance and refers to a 12-year-old male patient.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 03-MAY-2023, the patient was vaccinated with expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter, lot #1687293, expiration date: 30-APR-2023 (strength, and route of administration were not provided) administered for prophylaxis (expired product administered). No additional adverse event was reported.
Age: 30.0
Sex: F
Vaccine: HPV9
Symptoms: Maternal exposure during pregnancy
Clinical narrative: She received her second dose today, and she is 6 weeks pregnant.; No additional AE/No PQC; This spontaneous report was received from consumer and refers to a 30-year-old female patient.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 28-FEB-2023, the patient was vaccinated with first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (strength, lot #, expiry date, and route of administration were not provided) administration for prophylaxis. On 03-MAY-2023 (also reported as today), she was vaccinated with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter (strength, lot #, expiry date, and route of administration were not provided) administration for prophylaxis. Consumer stated she informed the healthcare proffesyinal (HCP) on her intake form that she was pregnant, and she was vaccined anyway (exposure during pregnancy). The date of last menstrual period (LMP), date of conception and due date is not reported. No additional adverse event was reported.
Sex: F
Vaccine: HPV9
Symptoms: Full blood count, Product use issue, Retinal exudates
Clinical narrative: Roth spot on her eye; Indication:had a pap smear that showed I have HPV high risk strain, showed ASCUS"; This spontaneous report as received from a consumer refers to a 39-year-old female patient, no pregnnat nad  with no present medical history. Current conditions include:  allergy to Erythromycin reported as Arythomicin. Historical vaccine include a vaccination of COVID (manufacturer unknown), on an unknown date, reported as over 3 months.   Concomitant therapies included docosahexaenoic acid, eicosapentaenoic acid(VEGETARIAN OMEGA 3), cyanocobalamin(B12-VITAMIN) and colecalciferol(VITAMIN D3).    On 12-DEC-2022 and 13-MAR-2023, the patient was vaccinated with a first and second dose of  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) intramuscular (strengths, lot #s and expiration dates were not provided) respectively,  for high risk HPV strain, because the patient had a pap smear that showed "ASCUS", date unspecified (Product use issue).  The caller reported she went to the eye doctor on 29-APR-2023, and the doctor found a Roth spot (Retinal exudates) on her eye. The caller said her doctor told her this could be caused by COVID, chronic high blood pressure or leukemia, but all of these had been ruled out as causes for this patient. The caller also said they mentioned it could be from a COVID vaccine, but the caller said she has not had a COVID vaccine in over 3 months (date unknown). The caller said they checked her complete blood count, on an unknown date  and confirmed she did  not have leukemia.  The outcome of retinal exudates was reported as not recovered/not resolved. Causality for retinal exudates and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was unspecified.  Upon internal review retinal exudates was considered to be medically significant.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Vaccination failure
Clinical narrative: Flu/Suspected vaccination failure; Flu; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, an unknown time after receiving Flu vaccine, the patient experienced vaccination failure (Verbatim: Flu/Suspected vaccination failure) (serious criteria GSK medically significant) and influenza (Verbatim: Flu). The outcome of the vaccination failure was unknown and the outcome of the influenza was not reported.   It was unknown if the reporter considered the vaccination failure and influenza to be related to Flu vaccine.     It was unknown if the company considered the vaccination failure and influenza to be related to Flu vaccine.   Additional Information: GSK Receipt Date: 28-APR-2023 This case was reported via interactive digital media. The reporter stated that everyone he/she know who got this Flu shot still got Flu. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming flu were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. This case had been linked with US2023AMR063816, reported by same reporter.; Sender's Comments:  US-GSK-US2023AMR063816:Same reporter. Shingles vx case